Hema Diagnostics

Hema Diagnostic Systems (HDS) is a medical technology company specializing in the development and manufacture of rapid in-vitro diagnostic (IVD) assays for infectious diseases. The company's proprietary RAPID 1-2-3 HEMA EXPRESS platform provides point-of-care testing solutions designed for use in resource-limited settings, offering results for HIV, tuberculosis, malaria, and syphilis. HDS products are recognized by international health organizations such as the WHO and CDC, and are utilized in global health programs like PEPFAR. Headquartered in Miramar, Florida, the company was acquired by Generex Biotechnology to integrate diagnostic capabilities with vaccine development.